Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with
AIDS-related Kaposi's sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborators:
AIDS Associated Malignancies Clinical Trials Consortium National Cancer Institute (NCI)